Research ID
hum0300-v1Release info
Research title
Whole-genome and whole-exome analyses of cancer
Research overview
- Aims
- We perform integrative genome-wide analyses such as whole-exome sequencing, epigenome analysis, copy number variant (CNV) analysis, and gene expression analysis using next-generation sequencing and other methods to elucidate driver genes and signaling pathways causing tumorigenesis and cancer progression, leading novel molecular diagnostics and molecular therapies.
- Methods
- Whole-exome sequencing, RNA-sequencing
- Participants/materials
- Whole-exome sequencing, Esophageal squamous cell carcinoma, tumor and paired non-tumor, 88 pairs; RNA-sequencing, Esophageal squamous cell carcinoma, tumor and paired non-tumor, 57 pairs
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000481 | NGS (Exome, RNA-seq) |
| Controlled-access (Type I) | 2021-11-30 |
Data provider
- Principal investigator
- Johji Inazawa
- Affiliation
- Department of molecular cytogenetics, Medical Research Institute, Tokyo Medical and Dental University
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area) | Establishment of novel concept for cancer diagnostics and therapeutics based on the systematic comprehension of cellular context in cancer |
|
Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Japan Agency for Medical Research and Development (AMED) | Identification of novel therapeutic target molecules and diagnostic biomarkers for esophageal squamous cell carcinoma |
|
Tailor-Made Medical Treatment with the BioBank Japan Project (BBJ), Japan Agency for Medical Research and Development (AMED) | Research and development for tailor-made cancer treatment based on integrative genome analyses |
|
Tokyo Medical and Dental University, Nanken-Kyoten | N/A | N/A |
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma |
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 | |
| Satoshi Fujii | Molecular pathology, Yokohama City University | Japan | A observational study to control the accuracy of PD-L1 immunohistochemistry and to elucidate the biological significance of the staining affinity in squamous cell carcinoma across multiple organs | 2025-10-07 – 2026-07-23 |